Preview Mode Links will not work in preview mode

Houston Healthcare Initiative's Podcast

Aug 23, 2020

Early in the pandemic, hydroxychloroquine looked like it could be a promising treatment for COVID-19 but use of the drug quickly lost favor after articles in the Lancet and New England Journal of Medicine cast doubt. Both journals retracted the articles but the damage was done. Listen to Dr. Steven Goldstein describe how and why this went wrong.